ScienceDaily (Apr. 29, 2009) — An influenza vaccine that protects against death and serious complications from different strains of flu is a little closer to reality, Saint Louis University vaccine researchers have found.

"This is a significant first step in developing a universal vaccine to help protect against pandemic influenza," said Robert Belshe, M.D., director of the Saint Louis University Center for Vaccine Development.

Belshe, the lead researcher who studied a vaccine made with proteins from strains of influenza viruses A and B, presents his findings on April 27 at the National Foundation for Infectious Disease Conference for Vaccine Research in Baltimore.

Currently drug companies manufacture a different flu vaccine each year to match the strains of influenza that researchers predict will circulate. Adding a universal influenza vaccine to a seasonal vaccine would help improve protection against strains of influenza as they change each year.

"Novel vaccines, capable of inducing long-lasting, broad immunity against divergent strains, including potential pandemic viruses, are highly desirable," Belshe said.

In the study, 377 healthy adults received three injections of a universal influenza vaccine, known as Bivalent Influenza Peptide Conjugate Vaccine (BIPCV), over a six month period.

Researchers found that a low dose of the vaccine is well tolerated and safe, Belshe said. It addition, the low dose vaccine evoked an immune response – high antibody titers – that is similar to levels associated with protecting small animals infected with influenza from serious disease and death. More testing is needed, Belshe added.

The research also is significant in light of the search for a vaccine to protect against a deadly influenza pandemic, which is a global outbreak of the disease that spreads quickly with lethal consequences.

Story Source:

Adapted from materials provided by Saint Louis University, via EurekAlert!, a service of AAAS.

Related Stories

Researchers Test New Vaccine To Fight Multiple Influenza Strains (Aug. 22, 2008) — A universal vaccine effective against several strains of influenza has passed its first phase of testing. VaxInnate's M2e universal vaccine could possibly protect against seasonal and pandemic ...  > read more

Universal Flu Vaccine Being Tested On Humans (July 18, 2007) — A universal influenza vaccine that has been pioneered by researchers from VIB and Ghent University is being tested for the first time on humans by the British-American biotech company Acambis. This ...  > read more

Bird Flu Vaccine Protects People And Pets (Oct. 20, 2008) — A single vaccine could be used to protect chickens, cats and humans against deadly flu pandemics, according to a new article published in the Journal of General Virology. The vaccine protects birds ...  > read more

Swine Flu Or Bird Flu: Scientist Warns Of Six-Month Time Lag To Manufacture Pandemic Flu Vaccine (May 1, 2009) — New research warns of a six-month time lag before effective vaccines can be manufactured in the event of a pandemic flu outbreak. By that time, the first wave of pandemic flu may be over before ...  > read more

Search ScienceDaily

Faster Flu Vaccine